Por favor, actualice su navegador

Nos tomamos muy en serio su seguridad. Para protegerle a usted y a nuestros sistemas, estamos realizando cambios en todos los sitios web de HSBC, lo que significa que algunas de las versiones más antiguas de los navegadores web ya no podrán acceder a dichas páginas. En general, las versiones más recientes de un navegador (como Edge, Chrome, Safari, etc.) y una familia de sistemas operativos (como Microsoft Windows, MacOS) tienen las características de seguridad más actualizadas.

Si está viendo este mensaje, hemos detectado que está utilizando un navegador antiguo no compatible.

Vea cómo actualizar su navegador

Building the future together

Making healthcare sustainable

HSBC GIF Global Equity Sustainable Healthcare

HSBC Asset Management is proud to announce the launch of its first Sustainable Healthcare Equity fund, a thematic fund that aims to achieve a sustainable investment in healthcare without sacrificing financial performance over the long term

 

We are delighted to collaborate with the Financial Times on a series of four articles exploring the state of the healthcare industry – the paradigm shift it’s undergoing and the implications; debunking commonly shared mindsets; examination of cost constraints; how, why, and where the industry is changing; and touching on the companies driving sustainable innovation. Read the full articles below.

Sustainable Healthcare : an investment opportunity

Interview of Dr. Michael Schröter and Dr. Nathalie Flury, Co-Heads of Sustainable Healthcare Equity.

HSBC GIF Global Equity Sustainable Healthcare, an innovative and differentiated investment approach

  • A thematic fund that aims to achieve a sustainable investment in healthcare without sacrificing financial performance over the long term
  • High conviction and bottom-up analysis paired with macro-economic trend
  • Sustainable, long-term growth oriented

Focus on HSBC GIF Global Equity Sustainable Healthcare

A changing market environment, where customers increasingly demand products and services that improve patient outcomes as well as being cost effective, requires a change in investment strategy. By following an active, bottom-up approach the fund aims to provide attractive returns whilst investing in companies offering affordable innovation with distinct clinical differentiation.

Article 8 SFDR: the product promotes environmental or social characteristics, or a combination of those characteristics, provided that the companies in which the investments are made follow good governance practices even if this is not its central point, or the central point of the investment process.
The objectives are to be considered on the recommended minimum investment period; there can be no assurance that the strategy of the fund will achieve these objectives. The comments reflect the opinion of HSBC Asset Management on the markets, according to the information available to date. They do not constitute any kind of commitment from HSBC Asset Management, which cannot be held responsible for any investment or disinvestment decision taken on the basis of these comments.

Experienced and complementary healthcare investment experts

The strategy is managed by two co-heads of Sustainable Healthcare Equity who have a successful track record managing healthcare equity strategies and who previously held executive positions in the pharma and biotech industries.

The investment team will leverage on proprietary insights driven by extensive global resources in equity and ESG research and stewardship.

Dr. Nathalie Flury


Dr. Nathalie Flury
20+ years’ experience as a fund manager, managing four European-based biotech and healthcare Lux. SICAV mutual funds and track record with custom made biotech and medtech mandates for family offices

Dr. Michael Schröter


Dr. Michael Schröter
20+ years’ Pharma and Biotech experience in executive positions, covering access and pricing, R&D, business development and licensing in the US, Asia and the EU

Fund details

Fund domicile

UCITS, Luxembourg SICAV

Fund launch date

28 July 2021

Strategy launch date

23 April 2019

Benchmark (for information only)

MSCI World Health Care Index (USD)

ISIN

AC: LU2324357040
IC: LU2324357396

Asset Class

Equity

Fund base currency

USD

Dealing currencies

EUR, GBP, CHF, AUD, HKD, CNH, SGD

Fees and expenses

Management fees : 1.50% (A Share Class) | 0.75% (I Share Class)
Operating, Administrative & Servicing Expenses : 0.35% (A Share Class) | 0.25% (I Share Class)

Minimum Initial Investment

A Share Class: USD 5,000 & I Share Class: USD 1,000,000
  • Sustainable investments

    Sustainable investments

    Solutions based on client need, designed to mitigate risk and capture opportunities around environmental, social and governance (ESG) issues.
  • Equities

    Equities

    Our wide range of innovative, client-focused equity solutions across the investment spectrum are all driven by proprietary fundamental research and a robust investment process.

Key Risks and Summary Risk Indicators

The value of an investment in the portfolios and any income from them can go down as well as up and as with any investment you may not receive back the amount originally invested.

Main risks of the fund:

  • Capital loss risk: It is important to remember that the value of investments and any income from them can go down as well as up and is not guaranteed.
  • Equity risk: Funds that invest in securities listed on a stock exchange or market could be affected by general changes in the stock market. The value of investments can go down as well as up due to equity markets movements.
  • Discretionary management risk: Discretionary management is based on anticipating the evolution of different markets and securities. There is a risk that the fund will not be invested at any time in the most efficient markets and securities.
  • Foreign Exchange risk: Where overseas investments are held, the rate of exchange of the currency may cause the value to go down as well as up. Variations in exchange rates between currencies can have a significant impact on the performance of the products presented.
  • Small caps risk: Please note that the fund is invested in securities issued by companies which, due to their small market capitalization, are less liquid and may present higher risks.

The SRI (Summary Risk Indicator) is an overall indicator of the product risk level. The scale varies from 1 (least risky) to 7 (most risky). Historical data may not be a reliable indication for the future. The rating is not guaranteed to remain unchanged and the categorisation may shift over time. The lowest rating does not mean a risk-free investment. Do not run any unnecessary risk. Read the Key Information Document.

Summary Risk Indicator (SRI) = 6 out of 7
SRI >= 4. The fund has a high risk indicator. The value of investments can go up as well as down.

Important information

HSBC GIF Global Equity Sustainable Healthcare is a sub fund of HSBC Global Investment Funds, a Luxemburg domiciled SICAV. 

Before subscription, investors should refer to Key Investor Document (KID) of the fund as well as its complete prospectus. For more detailed information on the risks associated with this fund, investors should refer to the complete prospectus of the fund.

The shares of HSBC Global Investment Funds have not been and will not be offered for sale or sold in the United States of America, its territories or possessions and all areas subject to its jurisdiction, or to United States Persons.

Past performance is no guarantee of future returns. Future returns will depend inter alia on market developments, the fund manager’s skill, the fund’s level risk and management costs and if applicable subscription and redemption costs. The return, the value of money invested in the fund may become negative as a result of price losses and currency fluctuations. There is no guarantee that all of your invested capital can be redeemed. Unless stated otherwise, inflation is not taken into account.

The fund uses the swing principle calculation method which determines the net asset value of the fund. Swing pricing allows investment funds to pay the daily transaction costs arising from subscription and redemptions by incoming and outgoing investors. The aim of swing pricing is to reduce the dilution effect generated when, for example, major redemptions in a fund force its manager to sell the underlying assets of the fund. These sales of assets generate transaction costs and taxes, also significant, which impact the value of the fund and all its investors. 

The fund has a redemption threshold (gate), the level at which the manager of an undertaking for collective investment in transferable securities can stagger the redemption of securities instead of proceeding immediately. 

The commentary and analysis presented in this document reflect the opinion of HSBC Asset Management on the markets, according to the information available to date. They do not constitute any kind of commitment from HSBC Asset Management. Consequently, HSBC Asset Management will not be held responsible for any investment or disinvestment decision taken on the basis of the commentary and/or analysis in this document.  

Tax treatment depends on The individual circumstances of each client and may be subject to change in the future.